zPost The Next Equity #Rocketz – Format $xxxx
Subscribe to the thread to receive e-mail(s) on The $NEXT #RKTZ.
Discuss Equity; Your DD – Due Diligence
Zest2U4U-Jammin’
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
$TLOG – Chart http://tos.mx/asRAss
$CXRX Flag breaks to upside and look for $10.50-$11.00 first trgt @MichaelJRIch:large
https://twitter.com/silvertonstock/status/768313814953570304
#SR082816 – https://stockreversals.com/2016/08/28/weekly-forecast-danger-ahead/ Disclosure: Not affiliated, not a recommendation, received zero pecuniary value. ~ Ben
#Premarket Top % Gainers: $ATEC 18%, $MGT 7%, $AVHI 4%, $FRO 4%, $AQXP 4%, $DRD 3%, $DGAZ $AMFW $YINN $SDRL $UN $UL $LN $BTI $SNN $GSK $BZH via @Super1NYC T.G.I.F.
#Premarket Top % Gainers: $ORIG 21%, $ATEC 18%, $JNUG 15%, $GSV 13%, $NUGT 11%, $PPHM $CPRX $TGD $FSM $SKLN $BTG $USLV $BTG $VGZ $MGT $CDE via ACE
#Premarket Top % Gainers: $NAVB 58%, $CPHD 52%, $CLCD 40%, $NAV 29%, $DVAX 16%, $THLD 15%, $SE 7% $VJET $REN $GPL $JNUG $DDD $NUGT $UWTI $AG
$SKLN – Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY waste fluid disposal system for medical applications, is issuing a reminder that it will hold a business update conference call on Thursday, September 8, 2016 to discuss its proposed joint venture with Electronic On-Ramp and other corporate activities, and its upcoming Special Meeting of Stockholders to be held on September 15, 2016.
The conference call is scheduled to begin at 12:00 p.m. Eastern Time.
To access the conference call, U.S.-based listeners should dial 844-751-1093 and international listeners should dial 574-990-2954. All listeners should provide the following passcode: 73407900. Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company’s website at http://www.skylinemedical.com.
Following the conclusion of the conference call, a replay will be available through September 14, 2016 and can be accessed by dialing 855-859-2056 from within the U.S. or 404-537-3406 from outside the U.S. All listeners should provide passcode 73407900. The webcast will be available for 30 days.
$SKLN
Skyline Medical Effects 1-For-25 Reverse Stock Split
Globe Newswire
Ace @Super1NYC 26m26 minutes ago View translation
#Premarket Top % Gainers: $IDXG 36%, $SSH 22%, $SWC 19%, $FGP 9%, $FNSR 8%, $MPEL 6%, $AVGO $WYNN $NVCN $DYN $LVS $NAK $OCLR $DNN $CCJ $BIIB
https://twitter.com/Super1NYC/status/807219510742831104
My Watchlist for Monday, December 12 http://ac-investor.blogspot.com/2016/12/my-watchlist-for-monday-december-12.html … $AAPL $DNAI $IONS $KR $OPXA $PYPL $SYY $WINT Have a great weekend everyone !! https://twitter.com/ACInvestorBlog/status/807726044962848768
upcoming #earnings – $GS $C $CSX $USB $UAL $FAST $ASML $AMTD $IBKR $NTRS $ADTN $SCHW $CBSH $PNFP $HBHC $LLTC $CTBI http://eps.sh/cal
https://twitter.com/eWhispers/status/821366248273547264
#Premarket Top % Gainers: $NQ 15%, $BIOL 13%, $GLBS 9%, $NAK 8%, $CYNO 8%, $ETRM 8%, $GLF 7% $HTBX $IMNP $JNUG $CTRN $SBGL $TBIO $NUGT $BNCN https://twitter.com/Super1NYC/status/823507671068409858
#Research
$MRTX – https://www.stockgumshoe.com/2016/12/the-twelve-biotechs-of-christmas-one/comment-page-5/#comment-4913510
https://twitter.com/Lin_ling_88/status/879428742678007809
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma. – https://www.ncbi.nlm.nih.gov/pubmed/28440559
https://twitter.com/CaesarBiotech/status/879302375214899200
http://www.mirati.com/go/
Om: https://www.stockgumshoe.com/2015/02/microblog-the-zed-files/comment-page-3/#comment-4369901
Om: https://www.stockgumshoe.com/2015/01/the-long-case-for-receptos/comment-page-4/#comment-4240788
ZKSS https://www.stockgumshoe.com/2015/02/microblog-the-zed-files/comment-page-3/#comment-4370481
#Research cont…
$MRTX main slides #JEFHC17
Sitravatinib, pan-RTK inhibitor, definitely the best asset of Mirati (preclinical KRAS too).
https://twitter.com/CaesarBiotech/status/874213708704231425
Sitravatinib $MRTX
1. NO competition for CHR4q12 and CBL mutations
2. First-in-Class TAM inhibitor = relevance for I/O combinations
https://twitter.com/CaesarBiotech/status/874214831267696640
$MRTX np – Additional excellent research provided by Helen
https://www.stockgumshoe.com/2017/06/oncotutorial/comment-page-14/#comment-4945201 (replace . w/ f 4 link) and nature article on #chromatin, #epigenetics amd #crisper: https://www.stockgumshoe.com/2017/06/oncotutorial/comment-page-14/#comment-4945181
$MRTX related – Anti-Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action
http://www.cell.com/immunity/fulltext/S1074-7613(17)30319-9
$MRTX related – p53 binding sites in normal and cancer cells are characterized by distinct chromatin context. https://www.ncbi.nlm.nih.gov/pubmed/28820292
Linker histone H1 prevents R-loop accumulation and genome instability in heterochromatin. https://www.ncbi.nlm.nih.gov/pubmed/28819201
$MRTX related – Kinetochore Components Required for Centromeric Chromatin Assembly Are Impacted by Msc1 in Schizosaccharomyces pombe.]
https://www.ncbi.nlm.nih.gov/pubmed/28827290?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter
The Yeast Heterochromatin Protein Sir3 Experienced Functional Changes in the AAA+ Domain After Gene Duplication and Subfunctionalization.
https://www.ncbi.nlm.nih.gov/pubmed/28827288?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter
$MRTX Understanding c-MET signalling in squamous cell carcinoma of the head & neck
http://www.croh-online.com/article/S1040-8428(17)30005-7/pdf … … via
https://twitter.com/CaesarBiotech/status/906593960885440512
:large
$SGMO np – Jefferies raising $SGMO PT to $18.00
#Partnerships ALZHEIMER
https://twitter.com/_B_I_O_T_E_C_H_/status/896096258816843776
$SGMO Positioned For An Upside Breakout
https://twitter.com/ACInvestorBlog/status/896312402203074560
$SGMO xenotransplantation
zinc finger gene editing pigs for transplanting organs into human
#lung #pancreas #heart #liver #kidney #cornea
https://twitter.com/_B_I_O_T_E_C_H_/status/896654022513446913
while CRISPR gets the hype
This CO gets it done $SGMO development of humanized donor animals for xenotransplantation
http://sangamodomain.blogspot.be/2017/07/xenotransplantation.html …
https://twitter.com/_B_I_O_T_E_C_H_/status/896634853608882177
Antonio Costa @ACInvestorBlog 13m
$SGMO at breakout point in pre-market. Could squeeze over 10.5
https://twitter.com/ACInvestorBlog/status/897066442016919552
#Premarket Top % Gainers: $SDLP 24% $GST 14% $SSI $BIOC $KL $BABA $UVXY $TVIX $HMY $AABA $TVIX $GFI $INFY $SRUN $NTNX $VXX $HMNY $DGAZ $SHPG https://twitter.com/Super1NYC/status/898161260730228736
$JCP – August 18, 2017 3:20 pm ET
*JC Penney CEO Buys 100K @$3.48/Share -Form 4 Benzinga
#Premarket Top % Gainers: $KITE 28%, $FRSX 15%, $JUNO $MSDI $AVEO $BLCM $QURE $CLLS $LABU $AG $ADMS $JNUG $DGAZ $FCX $NUGT $AU $JMEI $DWT https://twitter.com/Super1NYC/status/902134269631496192
Biotech Bonanza… as of this morning, 21 healthcare #IPOs were up, on average, 47% above their IPO price. $IBB boom!
https://twitter.com/IPOBoutique/status/908040936143409152